125 related articles for article (PubMed ID: 7794259)
1. Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of Wortmannin on phosphoinositide 3-kinase and aggregation.
Zhang J; Rittenhouse SE
Biochem Biophys Res Commun; 1995 Jun; 211(2):484-90. PubMed ID: 7794259
[TBL] [Abstract][Full Text] [Related]
2. Wortmannin inhibits serum-induced activation of phosphoinositide 3-kinase and proliferation of CHRF-288 cells.
Vemuri GS; Rittenhouse SE
Biochem Biophys Res Commun; 1994 Aug; 202(3):1619-23. PubMed ID: 8060348
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin.
Zhang J; Zhang J; Shattil SJ; Cunningham MC; Rittenhouse SE
J Biol Chem; 1996 Mar; 271(11):6265-72. PubMed ID: 8626420
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
Shah BH; Saeed SA
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):157-64. PubMed ID: 8556270
[TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation.
Kovacsovics TJ; Bachelot C; Toker A; Vlahos CJ; Duckworth B; Cantley LC; Hartwig JH
J Biol Chem; 1995 May; 270(19):11358-66. PubMed ID: 7744773
[TBL] [Abstract][Full Text] [Related]
6. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function.
McLane MA; Gabbeta J; Rao AK; Beviglia L; Lazarus RA; Niewiarowski S
Thromb Haemost; 1995 Nov; 74(5):1316-22. PubMed ID: 8607116
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
Pandey D; Goyal P; Siess W
Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
[TBL] [Abstract][Full Text] [Related]
9. Amyloid beta peptide-activated signal pathways in human platelets.
Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets.
Gratacap MP; Payrastre B; Viala C; Mauco G; Plantavid M; Chap H
J Biol Chem; 1998 Sep; 273(38):24314-21. PubMed ID: 9733717
[TBL] [Abstract][Full Text] [Related]
11. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor analysis of LDL-induced platelet aggregation.
Vlasova II; Azizova OA; Lopukhin YuM
Biochemistry (Mosc); 1997 Mar; 62(3):307-11. PubMed ID: 9275303
[TBL] [Abstract][Full Text] [Related]
14. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
[TBL] [Abstract][Full Text] [Related]
15. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol (3,4,5)-trisphosphate stimulates phosphorylation of pleckstrin in human platelets.
Zhang J; Falck JR; Reddy KK; Abrams CS; Zhao W; Rittenhouse SE
J Biol Chem; 1995 Sep; 270(39):22807-10. PubMed ID: 7559410
[TBL] [Abstract][Full Text] [Related]
17. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
Vickers JD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627
[TBL] [Abstract][Full Text] [Related]
18. Wortmannin inhibits platelet aggregation produced by interaction of gamma-aminobutyric acid and the calcium tonophore, A23187.
Saeed SA; Connor JD; Rasheed H; Gilani AH; Lodhi S; Ali SS; Rashid S; Khan E; Shah BH
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):87-93. PubMed ID: 11458988
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
Sandmann G; Siess W; Essler M
Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-kinase induced activation and cytoskeletal translocation of protein kinase CK2 in protease activated receptor 1-stimulated platelets.
Nakanishi K; Toyoda H; Tanaka S; Yamamoto H; Komada Y; Gabazza EC; Hayashi T; Suzuki K; Ido M
Thromb Res; 2010 Dec; 126(6):511-6. PubMed ID: 21055793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
